These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1843256)

  • 1. Thymus reticulum of autoimmune mice. 3. Ultrastructural study of NOD (non-obese diabetic) mouse thymus.
    Nabarra B; Andrianarison I
    Int J Exp Pathol; 1991 Jun; 72(3):275-87. PubMed ID: 1843256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NOD fetal thymus organ culture: an in vitro model for the development of T cells involved in IDDM.
    Wilson SS; DeLuca D
    J Autoimmun; 1997 Oct; 10(5):461-72. PubMed ID: 9376074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance of T-cells to apoptosis in autoimmune diabetic (NOD) mice is increased early in life and is associated with dysregulated expression of Bcl-x.
    Lamhamedi-Cherradi SE; Luan JJ; Eloy L; Fluteau G; Bach JF; Garchon HJ
    Diabetologia; 1998 Feb; 41(2):178-84. PubMed ID: 9498651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High frequency of thymic ectopy in thyroids from autoimmune prone nonobese diabetic female mice.
    Many MC; Drexhage HA; Denef JF
    Lab Invest; 1993 Sep; 69(3):364-7. PubMed ID: 8377477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfer of autoimmune diabetes from diabetic NOD mice to NOD athymic nude mice: the roles of T cell subsets in the pathogenesis.
    Matsumoto M; Yagi H; Kunimoto K; Kawaguchi J; Makino S; Harada M
    Cell Immunol; 1993 Apr; 148(1):189-97. PubMed ID: 8098666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibronectin receptor defects in NOD mouse leucocytes: possible consequences for type 1 diabetes.
    Geutskens SB; Mendes-da-Cruz DA; Dardenne M; Savino W
    Scand J Immunol; 2004; 60(1-2):30-8. PubMed ID: 15238071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural history of insulin content in the pancreas of female and male non-obese diabetic mouse: implications for trials of diabetes prevention in humans.
    Valorani MG; Hawa MI; Buckley LR; Afeltra A; Cacciapaglia F; Pozzilli P
    Diabetes Metab Res Rev; 2004; 20(5):394-8. PubMed ID: 15343585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of bone marrow and thymus chimerism between non-obese diabetic (NOD) and NOD-E transgenic mice, on the expression and prevention of diabetes.
    Parish NM; Chandler P; Quartey-Papafio R; Simpson E; Cooke A
    Eur J Immunol; 1993 Oct; 23(10):2667-75. PubMed ID: 8405065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the thymus in nonobese diabetic mouse. I. Changes in the microenvironmental compartments.
    Savino W; Boitard C; Bach JF; Dardenne M
    Lab Invest; 1991 Mar; 64(3):405-17. PubMed ID: 2002657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low rate of proliferation in immature thymocytes of the non-obese diabetic mouse maps to the Idd6 diabetes susceptibility region.
    Bergman ML; Penha-Gonçalves C; Lejon K; Holmberg D
    Diabetologia; 2001 Aug; 44(8):1054-61. PubMed ID: 11484085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of glucose transporter-2 precedes insulin loss in the nonobese diabetic and the low-dose streptozotocin mouse models: a comparative immunohistochemical study by light and confocal microscopy.
    Reddy S; Young M; Poole CA; Ross JM
    Gen Comp Endocrinol; 1998 Jul; 111(1):9-19. PubMed ID: 9653017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric enumeration of mononuclear cell populations infiltrating the islets of Langerhans in prediabetic NOD mice: development of a model of autoimmune insulitis for type I diabetes.
    Jarpe AJ; Hickman MR; Anderson JT; Winter WE; Peck AB
    Reg Immunol; 1990-1991; 3(6):305-17. PubMed ID: 2132756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD3 antibody treatment stimulates the functional capability of regulatory T cells.
    Chatenoud L
    Novartis Found Symp; 2003; 252():279-86; discussion 286-90. PubMed ID: 14609225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the thymus of non-obese diabetic (NOD) mice: effect of transgene expression.
    O'Reilly LA; Healey D; Simpson E; Chandler P; Lund T; Ritter MA; Cooke A
    Immunology; 1994 Jun; 82(2):275-86. PubMed ID: 7523287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The non-obese diabetic (NOD) mouse: an animal model for autoimmune thyroiditis.
    Many MC; Maniratunga S; Denef JF
    Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 3():17-20. PubMed ID: 8986413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular matrix distribution and islet morphology in the early postnatal pancreas: anomalies in the non-obese diabetic mouse.
    Geutskens SB; Homo-Delarche F; Pleau JM; Durant S; Drexhage HA; Savino W
    Cell Tissue Res; 2004 Dec; 318(3):579-89. PubMed ID: 15480796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrastructural studies of mouse thymic reticulum. II. Non-epithelial component.
    Nabarra B; Andrianarison I
    Thymus; 1991 Feb; 17(1):39-61. PubMed ID: 2014522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of prophylactic insulin treatment on the number of ER-MP23+ macrophages in the pancreas of NOD mice. Is the prevention of diabetes based on beta-cell rest?
    Jansen A; Rosmalen JG; Homo-Delarche F; Dardenne M; Drexhage HA
    J Autoimmun; 1996 Jun; 9(3):341-8. PubMed ID: 8816969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and immunological basis of autoimmune diabetes in the NOD mouse.
    Yoshida K; Kikutani H
    Rev Immunogenet; 2000; 2(1):140-6. PubMed ID: 11324686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in adhesion markers, activation markers, and TcR in islet infiltrating vs. peripheral lymphocytes in the NOD mouse.
    Goldrath AW; Barber L; Chen KE; Alters SE
    J Autoimmun; 1995 Apr; 8(2):209-20. PubMed ID: 7612149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.